{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:33Z","timestamp":1793042793341,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.dmd.2025.100143","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:14:29Z","timestamp":1754450069000},"page":"100143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The neuroendocrine regulation of hepatic cytochrome P450 by N-methyl-D-aspartate receptors in the paraventricular and arcuate nuclei of the hypothalamus"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4820-9084","authenticated-orcid":false,"given":"Renata","family":"Puk\u0142o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bromek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Basi\u0144ska-Ziobro\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3925-3828","authenticated-orcid":false,"given":"Anna","family":"Haduch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Kuban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw J.","family":"Danek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1226-1721","authenticated-orcid":false,"given":"W\u0142adys\u0142awa A.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmd.2025.100143_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/17425250902973703","article-title":"The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat","volume":"5","author":"W\u00f3jcikowski","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100143_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/17425255.2021.1872543","article-title":"The regulation of liver cytochrome P450 expression and activity by the brain serotonergic system in different experimental models","volume":"17","author":"Bromek","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.dmd.2025.100143_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115006","article-title":"The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions","volume":"199","author":"Daniel","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100143_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/138920007781368872","article-title":"The regulation of liver cytochrome P450 by the brain dopaminergic system","volume":"8","author":"W\u00f3jcikowski","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"11","key":"10.1016\/j.dmd.2025.100143_bib5","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.bcp.2013.09.006","article-title":"Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450","volume":"86","author":"Bromek","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100143_bib6","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/dmd.117.079632","article-title":"Activation of 5-HT1A receptors in the hypothalamic paraventricular nuclei negatively regulates cytochrome P450 expression and activity in rat liver","volume":"46","author":"Bromek","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/dmd.118.083808","article-title":"Serotonin receptors of 5-HT2 type in the hypothalamic arcuate nuclei positively regulate liver cytochrome P450 via stimulation of the growth hormone-releasing hormone\/growth hormone hormonal pathway","volume":"47","author":"Bromek","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100143_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2016.04.017","article-title":"The reverse role of the hypothalamic paraventricular (PVN) and arcuate (ARC) nuclei in the central serotonergic regulation of the liver cytochrome P450 isoform CYP2C11","volume":"112","author":"Rysz","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.dmd.2025.100143_bib9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3390\/pharmaceutics13101643","article-title":"The selective NMDA receptor GluN2B subunit antagonist CP-101,606 with antidepressant properties modulates cytochrome P450 expression in the liver","volume":"13","author":"Bromek","year":"2021","journal-title":"Pharmaceutics"},{"issue":"23","key":"10.1016\/j.dmd.2025.100143_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316840","article-title":"Molecular mechanisms of the regulation of liver cytochrome P450 by brain NMDA receptors and via the neuroendocrine pathway\u2014a significance for new psychotropic therapies","volume":"24","author":"Puk\u0142o","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.dmd.2025.100143_bib11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/14737175.2019.1643237","article-title":"An update on NMDA antagonists in depression","volume":"19","author":"Pochwat","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.dmd.2025.100143_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1190324","article-title":"GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology","volume":"16","author":"Ge","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.dmd.2025.100143_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109378","article-title":"NMDA receptors as therapeutic targets for depression treatment: evidence from clinical to basic research","volume":"225","author":"Lv","year":"2023","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s11030-023-10656-0","article-title":"GluN2B subunit selective N-methyl-D-aspartate receptor ligands: democratizing recent progress to assist the development of novel neurotherapeutics","volume":"28","author":"Ugale","year":"2024","journal-title":"Mol Divers"},{"issue":"5","key":"10.1016\/j.dmd.2025.100143_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/ph17050639","article-title":"NMDA receptor antagonists: emerging insights into molecular mechanisms and clinical applications in neurological disorders","volume":"17","author":"Egunlusi","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.dmd.2025.100143_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40263-024-01123-x","article-title":"Research progress on NMDA receptor enhancement drugs for the treatment of depressive disorder","volume":"38","author":"Liu","year":"2024","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000126843","article-title":"Glutamate: a major excitatory transmitter in neuroendocrine regulation","volume":"61","author":"Brann","year":"1995","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1385\/ENDO:17:3:193","article-title":"Endogenous excitatory amino acid neurotransmission regulates thyroid-stimulating hormone and thyroid hormone secretion in conscious freely moving male rats","volume":"17","author":"Arufe","year":"2002","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib19","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/en.2017-03176","article-title":"Enhanced hypothalamic NMDA receptor activity contributes to hyperactivity of HPA axis in chronic stress in male rats","volume":"159","author":"Zhou","year":"2018","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.dmd.2025.100143_bib20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/ph17101265","article-title":"NMDA receptors: distribution, role, and insights into neuropsychiatric disorders","volume":"17","author":"Beaurain","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2-3","key":"10.1016\/j.dmd.2025.100143_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(97)10092-9","article-title":"CP-101,606, a potent neuroprotectant selective for forebrain neurons","volume":"331","author":"Menniti","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0028-3908(01)00191-5","article-title":"Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists","volume":"42","author":"Chazot","year":"2002","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.dmd.2025.100143_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100143_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00213-017-4823-2","article-title":"Antagonism at the NR2B subunit of NMDA receptors induces increased connectivity of the prefrontal and subcortical regions regulating reward behavior","volume":"235","author":"Gass","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"13","key":"10.1016\/j.dmd.2025.100143_bib25","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/s41386-020-00797-3","article-title":"Role of the medial prefrontal cortex in the effects of rapid acting antidepressants on decision-making biases in rodents","volume":"45","author":"Hales","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/endo.134.2.7905409","article-title":"Glutamate receptors in the rat hypothalamus and pituitary","volume":"134","author":"Meeker","year":"1994","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0306-4522(00)00411-5","article-title":"Localization of glutamatergic\/aspartatergic neurons projecting to the hypothalamic paraventricular nucleus studied by retrograde transport of [3H]D-aspartate autoradiography","volume":"101","author":"Cs\u00e1ki","year":"2000","journal-title":"Neuroscience"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100143_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2005.01.090","article-title":"Glutamatergic innervation of corticotropin-releasing hormone- and thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat","volume":"1039","author":"Wittmann","year":"2005","journal-title":"Brain Res"},{"issue":"4-6","key":"10.1016\/j.dmd.2025.100143_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.brainresbull.2006.05.006","article-title":"Glutamatergic innervation of growth hormone-releasing hormone-containing neurons in the hypothalamic arcuate nucleus and somatostatin-containing neurons in the anterior periventricular nucleus of the rat","volume":"70","author":"Kiss","year":"2006","journal-title":"Brain Res Bull"},{"issue":"7","key":"10.1016\/j.dmd.2025.100143_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/cne.22571","article-title":"Forebrain origins of glutamatergic innervation to the rat paraventricular nucleus of the hypothalamus: differential inputs to the anterior versus posterior subregions","volume":"519","author":"Ulrich-Lai","year":"2011","journal-title":"J Comp Neurol"},{"issue":"11","key":"10.1016\/j.dmd.2025.100143_bib31","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/cne.23043","article-title":"Brainstem origins of glutamatergic innervation of the rat hypothalamic paraventricular nucleus","volume":"520","author":"Ziegler","year":"2012","journal-title":"J Comp Neurol"},{"issue":"11","key":"10.1016\/j.dmd.2025.100143_bib32","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1210\/me.2006-0007","article-title":"Growth hormone regulation of sex-dependent liver gene expression","volume":"20","author":"Waxman","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100143_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/03602532.2010.484462","article-title":"Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids","volume":"42","author":"Dvorak","year":"2010","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/138920011795016881","article-title":"Role of retinoids, rexinoids and thyroid hormone in the expression of cytochrome P450 enzymes","volume":"12","author":"Brtko","year":"2011","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/138920011795016854","article-title":"Steroid regulation of drug-metabolizing cytochromes P450","volume":"12","author":"Monostory","year":"2011","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/138920011795016908","article-title":"The role of the nervous system in the regulation of liver cytochrome P450","volume":"12","author":"W\u00f3jcikowski","year":"2011","journal-title":"Curr Drug Metab"},{"issue":"8","key":"10.1016\/j.dmd.2025.100143_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425255.2025.2517731","article-title":"The effect of prolonged treatment with antipsychotic drugs on cytochrome P450\u2014drug metabolizing enzymes. Mechanisms of action and significance for pharmacotherapy","volume":"21","author":"Basi\u0144ska-Ziobro\u0144","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100143_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.euroneuro.2006.01.004","article-title":"Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment","volume":"16","author":"Daniel","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.dmd.2025.100143_bib40","author":"Paxinos","year":"2007"},{"issue":"5","key":"10.1016\/j.dmd.2025.100143_bib41","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s43440-020-00151-w","article-title":"The effects of agomelatine and imipramine on liver cytochrome P450 during chronic mild stress (CMS) in the rat","volume":"72","author":"Haduch","year":"2020","journal-title":"Pharmacol Rep"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/03602532.2015.1011658","article-title":"Regioselective hydroxylation of steroid hormones by human cytochromes P450","volume":"47","author":"Niwa","year":"2015","journal-title":"Drug Metab Rev"},{"issue":"12","key":"10.1016\/j.dmd.2025.100143_bib43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2217\/pgs-2018-0065","article-title":"Functional characterization of CYP2D7 gene variants","volume":"19","author":"Jukic","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.dmd.2025.100143_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100065","article-title":"In vitro-in vivo scaling of cytochrome P450-mediated metabolic clearance using a relative activity factor approach","volume":"53","author":"Nagaya","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2025.100143_bib45","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s43440-023-00540-x","article-title":"The effect of brain serotonin deficit (TPH2-KO) on the expression and activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats","volume":"75","author":"Haduch","year":"2023","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.dmd.2025.100143_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.phrs.2011.06.020","article-title":"Cytochrome P450 is regulated by noradrenergic and serotonergic systems","volume":"64","author":"Kot","year":"2011","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.dmd.2025.100143_bib47","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bcp.2013.07.017","article-title":"The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression","volume":"86","author":"Sadakierska-Chudy","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100143_bib48","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/dmd.115.064980","article-title":"Damage to the brain serotonergic system increases the expression of liver cytochrome P450","volume":"43","author":"Rysz","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100143_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105349","article-title":"The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences","volume":"48","author":"Pascussi","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100143_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/03602530903112284","article-title":"Hormonal regulation of CYP1A expression","volume":"41","author":"Monostory","year":"2009","journal-title":"Drug Metab Rev"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib51","first-page":"253","article-title":"Role of paraventricular nucleus glutamate signaling in regulation of HPA axis stress responses","volume":"21","author":"Evanson","year":"2015","journal-title":"Interdiscip Inf Sci"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1081\/DMR-46136","article-title":"Regulation of cytochrome P450 by posttranslational modification","volume":"37","author":"Aguiar","year":"2005","journal-title":"Drug Metab Rev"},{"issue":"7","key":"10.1016\/j.dmd.2025.100143_bib53","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bcp.2007.12.017","article-title":"Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence","volume":"75","author":"Kot","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1385\/ENDO:28:3:295","article-title":"Role of excitatory amino acids in the control of growth hormone secretion","volume":"28","author":"Aguilar","year":"2005","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.dmd.2025.100143_bib55","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0026-895X(25)10535-X","article-title":"Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate","volume":"48","author":"Waxman","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100143_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2015.01.014","article-title":"The role of the dorsal noradrenergic pathway of the brain (locus coeruleus) in the regulation of liver cytochrome P450 activity","volume":"751","author":"Kot","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100143_bib57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/dmd.31.1.76","article-title":"Metabolism, pharmacokinetics, and excretion of a highly selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in human cytochrome P450 2D6 extensive and poor metabolizers","volume":"31","author":"Johnson","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.dmd.2025.100143_bib58","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200645100-00003","article-title":"Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers","volume":"45","author":"Taylor","year":"2006","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.dmd.2025.100143_bib59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11011-016-9810-5","article-title":"Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice","volume":"31","author":"Poleszak","year":"2016","journal-title":"Metab Brain Dis"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(03)02182-4","article-title":"The effect of (+\/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze","volume":"476","author":"Guscott","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100143_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2967\/jnumed.120.246785","article-title":"Preclinical development of 18F-OF-NB1 for imaging GluN2B-containing N-methyl-d-aspartate receptors and its utility as a biomarker for amyotrophic lateral sclerosis","volume":"62","author":"Ahmed","year":"2021","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.dmd.2025.100143_bib62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00702-016-1657-8","article-title":"Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice","volume":"124","author":"Stasiuk","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.dmd.2025.100143_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1749-6632.1999.tb07980.x","article-title":"An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage","volume":"890","author":"Bullock","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.dmd.2025.100143_bib64","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2967\/jnumed.121.262427","article-title":"First-in-humans brain PET imaging of the GluN2B-containing N-methyl-d-aspartate receptor with (R)-11C-Me-NB1","volume":"63","author":"Rischka","year":"2022","journal-title":"J Nucl Med"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:42:15Z","timestamp":1758699735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0090955625091524"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100143","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuroendocrine regulation of hepatic cytochrome P450 by N-methyl-D-aspartate receptors in the paraventricular and arcuate nuclei of the hypothalamus","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100143"}}